Burcu Tunakan: Turning Collaboration into Better Outcomes for People with Hemophilia
Burcu Tunakan, Vice President of US Hematology and Endocrinology Franchise Lead at Pfizer, shared a post on LinkedIn:
“Today, we were thrilled to host our second Hemophilia Day at Pfizer Headquarters.
Leading Hematologists across the nation joined us for a day of candid dialogue and collaboration, at a time when the science in this space is advancing faster than ever.
We exchanged perspectives and insights which will shape our team’s actions to advance care for people living with Hemophilia.
Because there is still meaningful work ahead.
And our team is fully committed to turning breakthrough innovation into real, lasting patient impact, by listening deeply and working alongside this community every step of the way.
Thank you to every leading expert who joined us.
Your partnership makes the difference.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026